Login / Signup

Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic adenovirus.

Masashi HashimotoShinji KurodaNobuhiko KanayaDaisuke KadowakiYusuke YoshidaMasaki SakamotoYuki HamadaRyoma SugimotoChiaki YagiTomoko OhtaniKento KumonYoshihiko KakiuchiKazuya YasuiSatoru KikuchiRyuichi YoshidaHiroshi TazawaShunsuke KagawaTakahito YagiYasuo UrataToshiyoshi Fujiwara
Published in: British journal of cancer (2024)
OBP-702 can be a long-term immunostimulant with sustained anti-tumor effects on immunologically cold pancreatic cancer.
Keyphrases
  • gene therapy